Moonshots with Peter Diamandis

PHD Ventures
undefined
538 snips
May 9, 2026 • 2h 9min

Google's Record Quarter, the White House Intervenes, and GPT 5.5 Silently Matches Mythos | EP 254

Brian Elliott, Co-founder and CEO of Blitzy, leads an AI startup focused on autonomous enterprise software and large-codebase automation. He discusses Blitzy’s $200M raise and practical deployment experiences. The conversation covers Google’s AI-driven earnings, GPT‑5.5 vs Claude Mythos, compute scarcity, Pentagon and White House model oversight, ocean and orbital data centers, and private-equity–led enterprise AI shifts.
undefined
347 snips
May 7, 2026 • 1h 35min

Demis Hassabis on AGI, Robots Scale Production, and Elon’s $1T Mars-Shot Comp | EP #253

Dave Blundin, founder and VC with practical startup scaling chops. Salim Ismail, ExO founder and exponential-org strategist. Alex Wissner-Gross, MIT-trained computer scientist and entrepreneur. Steven Kotler, bestselling author on flow and peak performance. They debate Elon’s Mars compensation, nonprofit-to-for-profit AI shifts, robotics scaling and factories, humanoid vs specialized robots, trial fallout for OpenAI, and visions of AI-driven labs and consumer futures.
undefined
905 snips
May 4, 2026 • 2h 20min

Google Invests $40B Into Anthropic, GPT 5.5 Drops, and Google Cloud Dominates | EP #252

A fast tour through the AI arms race, from GPT 5.5 and Kimi K2.6 to the battle over chips, power, and cloud dominance. It also dives into self-hosted models, always-on assistants, deepfake-proof identity, AI reshaping jobs and medicine, and robotics finally moving into daily life.
undefined
312 snips
Apr 28, 2026 • 27min

David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251

David Sinclair, Harvard geneticist and longevity researcher, dives into AI finding new molecules in his lab, surprising concerns around GLP-1 drugs, and bold work on reversing blindness and other age-related decline. They also touch on telomeres, muscle and hormone support, stressed plants, indoor health, and the mindset behind aging well.
undefined
295 snips
Apr 27, 2026 • 33min

David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #250

David Sinclair, Harvard genetics professor and longevity biotech entrepreneur, dives into human age-reversal trials, why the eye is the first proving ground, and the race from gene therapy to a scalable longevity pill. He also gets into lifespan timelines, his current routine, heart-risk tracking, diet changes, and the role of sleep, stress, and social connection.
undefined
922 snips
Apr 23, 2026 • 2h 35min

Iran's AI Supply Chain Threat, Claude vs. SaaS, and Elon's $60B Cursor Bet | EP #249

In this episode, the mates center on the Iran oil shock as a broader system shock, Anthropic’s Claude Design and the “unhobbled” frontier-lab threat to vertical software, the AI job transition, UAP disclosure, the power and geopolitics of data centers, China’s solar and robotics push, and the future of entrepreneurship and agency. Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends   Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 Salim Ismail is the founder of OpenExO Dave Blundin is the founder & GP of Link Ventures Dr. Alexander Wissner-Gross is a computer scientist and founder of Reified – My companies: Apply to Dave's and my new fund:https://qr.diamandis.com/linkventureslanding      Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy   Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter  _ Connect with Peter: X Instagram Connect with Dave: Web X LinkedIn Instagram TikTok Connect with Salim: X Join Salim's Workshop to build your ExO  Connect with Alex Website LinkedIn X Email Substack  Spotify Threads Listen to MOONSHOTS: Apple YouTube – *Recorded on April 21st, 2026 *The views expressed by me and all guests are personal opinions and do not constitute Financial, Medical, or Legal advice. Learn more about your ad choices. Visit megaphone.fm/adchoices
undefined
787 snips
Apr 18, 2026 • 2h 12min

Sam Altman’s Attack, Amazon vs. Starlink, and What Opus 4.7 Actually Means | #248

AI panic spills into real-world attacks, while young workers face an early hiring squeeze and workers train systems that may replace them. The conversation jumps to AI-run stores, data centers moving off-planet, and Amazon challenging Starlink in the satellite race. Then it gets even wilder with AI-made religions, engineered sports, brain implants, immortality, mind uploads, and life beyond Earth.
undefined
905 snips
Apr 14, 2026 • 2h 12min

Elon Musk vs. Sam Altman, AI Job Loss, and OpenAI’s $852B Valuation | EP #247

AI power struggles take center stage as Elon Musk, Sam Altman, OpenAI, xAI, and Anthropic collide over lawsuits, valuations, and the race for agents. The conversation also dives into looming white-collar automation, humanoid robots in China, AI-designed drugs, Bitcoin’s quantum worries, and why energy, education, and EVs may be heading toward abundance.
undefined
1,163 snips
Apr 11, 2026 • 2h 29min

SpaceX Goes Public, Claude’s Mythos Release, and the US Data Center Delay | EP #246

A fast tour through SpaceX’s public-market buzz, Starlink’s real value, and the race for AI capital. Then it jumps to Claude’s Mythos release, enterprise AI rivalry, and strange questions about machine emotions. There’s also lunar missions, nuclear spacecraft, orbital data centers, quantum risk to Bitcoin, biotech deals, humanoid robots, and one-person unicorns.
undefined
146 snips
Apr 7, 2026 • 36min

How AI Is Bringing Extinct Animals Back (And What Comes Next) | Ben Lamm (Colossal) | EP #245

This episode was filmed at the 2026 Abundance360 Summit. Learn more at https://www.abundance360.com/  This interview explores the groundbreaking work of Colossal in synthetic biology, de-extinction, and AI integration. Colossal CEO Ben Lamm explains how the company is revolutionizing biodiversity preservation, tackling plastic pollution, and creating living products with immense potential. Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends   Ben Lamm is Co-founder and CEO of Colossal Biosciences Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 – My companies: Apply to Dave's and my new fund:https://qr.diamandis.com/linkventureslanding      Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy   Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter  _ Connect with Peter: X Instagram Connect with Ben X Instagram Linkedin Listen to MOONSHOTS: Apple YouTube – *Recorded on March 10th, 2026 *The views expressed by me and all guests are personal opinions and do not constitute Financial, Medical, or Legal advice. Learn more about your ad choices. Visit megaphone.fm/adchoices

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app